Showing results for:
Drug name(s)
Brukinsa® Zanubrutinib
Approved for
- Leukemia
- Chronic Lymphocytic Leukemia (CLL/SLL)
- Lymphoma
- Follicular Lymphoma (FL)
- Mantle Cell Lymphoma (MCL)
- Marginal Zone Lymphoma (MZL)
- Waldenström Macroglobulinemia (WM)
Drug name(s)
Komzifti™ Ziftomenib
Approved for
- Acute Myeloid Leukemia (AML)
Drug name(s)
Zometa® Zoledronic acid
Approved for
- Myeloma
- Other Blood Cancers